BioAmber IPO Research Information

BioAmber IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on BioAmber, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
BioAmber	BIOA - NYSE	$10.00-$12.00	$10.00	$10.00	8 million	5/10/2013
Underwriter(s): Credit Suisse
Co-Manager(s): Societe Generale, Barclays, Pacific Crest Securities
Industry: Energy
Filing(s): Filed 2011-11-14 Terms Added 2013-04-11

BioAmber Quote & Chart - Click for current quote - BIOA

About BioAmber (adapted from BioAmber prospectus):
They are a next-generation chemicals company; their technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals.

This description is adapted from BioAmber prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as BioAmber "BIOA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.